Patents by Inventor Alan M. Solinger

Alan M. Solinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR THE TREATMENT OF GOUT
    Publication number: 20210032326
    Abstract: Disclosed are methods for the treatment and/or prevention of gout, comprising administering to a subject an effective amount of anti-IL-1? antibody or fragment thereof.
    Type: Application
    Filed: March 13, 2020
    Publication date: February 4, 2021
    Applicant: XOMA (US) LLC
    Inventor: Alan M. Solinger
  • CARDIOVASCULAR RELATED USES OF IL-1BETA ANTIBODIES AND BINDING FRAGMENTS THEREOF
    Publication number: 20210009679
    Abstract: Disclosed are methods for the reduction, prevention or treatment of cardiovascular events and/or cardiovascular diseases, including acute cardiovascular disease or chronic cardiovascular disease using anti-IL-1? binding molecules (e.g., IL-1? binding antibodies and fragments thereof). The present disclosure also relates to methods for prevention or treatment of cardiovascular events and/or cardiovascular diseases, including by reducing a cardiovascular event or disease.
    Type: Application
    Filed: February 24, 2020
    Publication date: January 14, 2021
    Applicant: XOMA (US) LLC
    Inventors: Patrick J. Scannon, Alan M. Solinger, Jeffrey D. Feldstein
  • Cardiovascular related uses of IL-1? antibodies and binding fragments thereof
    Patent number: 10611832
    Abstract: Disclosed are methods for the reduction, prevention or treatment of cardiovascular events and/or cardiovascular diseases, including acute cardiovascular disease or chronic cardiovascular disease using anti-IL-1? binding molecules (e.g., IL-1? binding antibodies and fragments thereof). The present disclosure also relates to methods for prevention or treatment of cardiovascular events and/or cardiovascular diseases, including by reducing a cardiovascular event or disease.
    Type: Grant
    Filed: July 11, 2017
    Date of Patent: April 7, 2020
    Assignee: XOMA (US) LLC
    Inventors: Patrick J. Scannon, Alan M. Solinger, Jeffrey D. Feldstein
  • CARDIOVASCULAR RELATED USES OF IL-1BETA ANTIBODIES AND BINDING FRAGMENTS THEREOF
    Publication number: 20180155420
    Abstract: Disclosed are methods for the reduction, prevention or treatment of cardiovascular events and/or cardiovascular diseases, including acute cardiovascular disease or chronic cardiovascular disease using anti-IL-1? binding molecules (e.g., IL-1? binding antibodies and fragments thereof). The present disclosure also relates to methods for prevention or treatment of cardiovascular events and/or cardiovascular diseases, including by reducing a cardiovascular event or disease.
    Type: Application
    Filed: July 11, 2017
    Publication date: June 7, 2018
    Inventors: Patrick J. Scannon, Alan M. Solinger, Jeffrey D. Feldstein
  • METHODS FOR THE TREATMENT OF GOUT
    Publication number: 20170355764
    Abstract: Disclosed are methods for the treatment and/or prevention of gout, comprising administering to a subject an effective amount of anti-IL-1? antibody or fragment thereof.
    Type: Application
    Filed: January 30, 2017
    Publication date: December 14, 2017
    Inventor: Alan M. Solinger
  • Methods for the treatment of IL-1? related diseases
    Patent number: 9163082
    Abstract: Disclosed are methods for the treatment and/or prevention of Type 2 diabetes, insulin resistance and disease states and conditions characterized by insulin resistance, obesity, hyperglycemia, hyperinsulinemia and Type 1 diabetes, comprising administering to a subject an effective amount of anti-IL-1? antibody or fragment thereof.
    Type: Grant
    Filed: September 30, 2013
    Date of Patent: October 20, 2015
    Assignee: XOMA (US) LLC
    Inventors: Alan M. Solinger, Patrick J. Scannon, Robert J. Bauer
  • Methods for the treatment of uveitis with IL-1? binding antibodies
    Patent number: 9139646
    Abstract: Disclosed are methods and materials for inhibiting (e.g., treating or preventing) uveitis in a subject, including treatment refractory uveitis, using anti-IL-1? binding molecules (e.g., IL-1? binding antibodies or binding fragment thereof).
    Type: Grant
    Filed: September 17, 2013
    Date of Patent: September 22, 2015
    Assignee: XOMA (US) LLC
    Inventors: Alan M. Solinger, Ahmet Gül
  • METHODS FOR THE TREATMENT OF GOUT
    Publication number: 20140370002
    Abstract: Disclosed are methods for the treatment and/or prevention of gout, comprising administering to a subject an effective amount of anti-IL-1? antibody or fragment thereof.
    Type: Application
    Filed: December 20, 2013
    Publication date: December 18, 2014
    Applicant: XOMA (US) LLC
    Inventor: Alan M. Solinger
  • METHODS FOR THE TREATMENT OF IL-1BETA RELATED DISEASES
    Publication number: 20140255391
    Abstract: Disclosed are methods for the treatment and/or prevention of Type 2 diabetes, insulin resistance and disease states and conditions characterized by insulin resistance, obesity, hyperglycemia, hyperinsulinemia and Type 1 diabetes, comprising administering to a subject an effective amount of anti-IL-1? antibody or fragment thereof.
    Type: Application
    Filed: September 30, 2013
    Publication date: September 11, 2014
    Applicant: XOMA Technology Ltd.
    Inventors: Alan M. Solinger, Patrick J. Scannon, Robert J. Bauer
  • METHODS FOR THE TREATMENT OF IL-1BETA RELATED CONDITIONS
    Publication number: 20140242090
    Abstract: Disclosed are methods and materials for inhibiting (e.g., treating or preventing) uveitis in a subject, including treatment refractory uveitis, using anti-IL-1? binding molecules (e.g., IL-1? binding antibodies or binding fragment thereof).
    Type: Application
    Filed: September 17, 2013
    Publication date: August 28, 2014
    Applicant: XOMA Technology Ltd.
    Inventors: Alan M. Solinger, Ahmet Gül
  • Methods for the treatment of gout
    Patent number: 8637029
    Abstract: Disclosed are methods for the treatment and/or prevention of gout, comprising administering to a subject an effective amount of anti-IL-1? antibody or fragment thereof.
    Type: Grant
    Filed: December 18, 2008
    Date of Patent: January 28, 2014
    Assignee: XOMA Technology Ltd.
    Inventor: Alan M. Solinger
  • Methods for the treatment of IL-1? related diseases
    Patent number: 8586036
    Abstract: Disclosed are methods for the treatment and/or prevention of Type 2 diabetes, insulin resistance and disease states and conditions characterized by insulin resistance, obesity, hyperglycemia, hyperinsulinemia and Type 1 diabetes, comprising administering to a subject an effective amount of anti-IL-1? antibody or fragment thereof.
    Type: Grant
    Filed: April 9, 2010
    Date of Patent: November 19, 2013
    Assignee: XOMA Technology Ltd.
    Inventors: Alan M. Solinger, Patrick J. Scannon, Robert J. Bauer
  • Methods for the treatment of IL-1? related conditions
    Patent number: 8551487
    Abstract: Disclosed are methods and materials for inhibiting (e.g., treating or preventing) uveitis in a subject, including treatment refractory uveitis, using anti-IL-1? binding molecules (e.g., IL-1? binding antibodies or binding fragment thereof).
    Type: Grant
    Filed: May 6, 2011
    Date of Patent: October 8, 2013
    Assignee: Xoma Technology, Ltd.
    Inventors: Alan M. Solinger, Ahmet Gül
  • Methods for treating IL-1? related diseases by administering an anti-IL-1? antibody
    Patent number: 8545846
    Abstract: Disclosed are methods for the treatment and/or prevention of Type 2 diabetes, insulin resistance and disease states and conditions characterized by insulin resistance, decreased insulin production, hyperglycemia, hypoinsulinemia, metabolic syndrome, Type 1 diabetes and obesity, comprising administering to a subject an effective amount of anti-IL-1? antibody or fragment thereof.
    Type: Grant
    Filed: September 4, 2009
    Date of Patent: October 1, 2013
    Assignee: XOMA Technology, Ltd.
    Inventors: Patrick J. Scannon, Alan M. Solinger, Robert J. Bauer
  • Methods for improvement of beta cell function with anti-IL-1? antibodies or fragments thereof
    Patent number: 8377429
    Abstract: Disclosed are methods for improvement of beta cell function in a subject using an anti-IL-1? antibody or fragment thereof.
    Type: Grant
    Filed: September 4, 2009
    Date of Patent: February 19, 2013
    Assignee: Xoma Technology Ltd.
    Inventors: Patrick J. Scannon, Alan M. Solinger, Robert J. Bauer
  • Methods for the treatment of IL-1? related diseases
    Patent number: 8101166
    Abstract: Disclosed are methods for the treatment and/or prevention of Type 2 diabetes, insulin resistance and disease states and conditions characterized by insulin resistance, obesity, hyperglycemia, hyperinsulinemia and Type 1 diabetes, comprising administering to a subject an effective amount of anti-IL-1? antibody or fragment thereof.
    Type: Grant
    Filed: February 23, 2010
    Date of Patent: January 24, 2012
    Assignee: Xoma Technology Ltd.
    Inventors: Alan M. Solinger, Patrick J. Scannon, Robert J. Bauer
  • METHODS FOR THE TREATMENT OF IL-1BETA RELATED CONDITIONS
    Publication number: 20120014966
    Abstract: Disclosed are methods and materials for inhibiting (e.g., treating or preventing) uveitis in a subject, including treatment refractory uveitis, using anti-IL-1? binding molecules (e.g., IL-1? binding antibodies or binding fragment thereof).
    Type: Application
    Filed: May 6, 2011
    Publication date: January 19, 2012
    Applicant: XOMA TECHNOLOGY LTD.
    Inventors: Alan M. Solinger, Ahmet Gül
  • METHODS FOR TREATING OR PREVENTING IL-1BETA RELATED DISEASES
    Publication number: 20120003226
    Abstract: Disclosed are methods for the treatment and/or prevention of Type 2 diabetes, insulin resistance and disease states and conditions characterized by insulin resistance, decreased insulin production, hyperglycemia, hypoinsulinemia, metabolic syndrome, Type 1 diabetes and obesity, comprising administering to a subject an effective amount of anti-IL-1? antibody or fragment thereof.
    Type: Application
    Filed: September 4, 2009
    Publication date: January 5, 2012
    Applicant: XOMA TECHNOLOGY LTD.
    Inventors: Patrick J. Scannon, Alan M. Solinger, Robert J. Bauer
  • METHODS FOR IMPROVEMENT OF BETA CELL FUNCTION
    Publication number: 20120005127
    Abstract: Disclosed are methods for improvement of beta cell function in a subject using an anti-IL-1? antibody or fragment thereof.
    Type: Application
    Filed: September 4, 2009
    Publication date: January 5, 2012
    Applicant: XOMA TECHNOLOGY LTD.
    Inventors: Patrick J. Scannon, Alan M. Solinger, Robert J. Bauer
  • METHODS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
    Publication number: 20110189172
    Abstract: Disclosed are compositions and methods for the treatment and/or prevention of rheumatoid arthritis, comprising administering to a subject an effective amount of anti-IL-1? antibody or fragment thereof.
    Type: Application
    Filed: June 5, 2009
    Publication date: August 4, 2011
    Applicant: XOMA TECHNOLOGY, LTD.
    Inventors: Alan M. Solinger, Alexander Owyang